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Several 3-keto-synthases have been studied, including the soluble
fatty acid synthases, those involved in polyketide synthesis, and the
FAE1-like 3-ketoacyl-CoA synthases. All of these condensing
enzymes have a common ancestor and an enzymatic mechanism
that involves a catalytic triad consisting of Cys, His, andHis/Asn. In
contrast to the FAE1-like family of enzymes that mediate plant
microsomal fatty acid elongation, the condensation step of elonga-
tion in animals and in fungi appears to be mediated by the Elop
homologs. Curiously these proteins bear no resemblance to thewell
characterized 3-keto-synthases. There are three ELO genes in yeast
that encode the homologous Elo1p, Elo2p, and Elo3p proteins.
Elo2p and Elo3p are required for synthesis of the very long-chain
fatty acids, and mutants lacking both Elo2p and Elo3p are inviable
confirming that the very long-chain fatty acids are essential for cel-
lular functions. In this study we show that heterologous expression
of several Arabidopsis FAE1-like genes rescues the lethality of an
elo2elo3 yeast mutant. We further demonstrate that FAE1 acts
in conjunctionwith the 3-keto and trans-2,3-enoyl reductases of the
elongase system. These studies indicate that even though the plant-
specific FAE1 family of condensing enzymes evolved independently
of the Elop family of condensing enzymes, they utilize the same
reductases and presumably dehydratase that the Elop proteins rely
upon.
Cytosolic fatty acid synthases catalyze the de novo synthesis of the
majority of cellular fatty acids, which have 16 or 18 carbons. However,
there are many other types of fatty acids in the cellular lipids, including
the very long-chain fatty acids (VLCFA)2 that are synthesized through
elongation of the C16 or C18 fatty acid by amicrosomal enzyme system.
The VLCFAs have been implicated in a number of cellular processes,
including the formation of nuclear pores, trafficking of lipids and pro-
teins, and the formation of membrane domains that organize signaling
proteins. In higher plants, VLCFAs are critical components of thewaxes
found in the pollen coat and in leaves, and they are also found in the
storage triacylglycerols of some seeds. Very long chain polyunsaturated
fatty acids, including arachidonic acid, eicosapentaenoic acid, and doco-
sahexaenoic acid, are abundant in the membranes of brain and retina,
and they serve as precursors of the biologically active eicosanoids.
Despite mounting evidence that the VLCFAs are important in cellular
physiology, many aspects of their synthesis and function remain to be
resolved.
In yeast the saturatedVLCFAs are present in the sphingolipids, which
are essential for cell viability. Interestingly, a mutation that leads to the
synthesis of C26-containing phosphatidylinositol can bypass the
requirement for sphingolipids (though the mutant strains grow poorly)
highlighting the importance of the VLCFA (1, 2). It is now well estab-
lished that the Elop proteins are components of the membrane-associ-
ated elongase system that mediates VLCFA synthesis. Elo1p is involved
in the elongation ofmedium-chain fatty acids, whereas Elo2p and Elo3p
participate in the elongation of C16 to C24, and Elo3p is required for
elongating C24 to C26 (3–6). Yeast transformed with foreign ELO
homologs synthesize novel (e.g.mono- and polyunsaturated) elongated
fatty acids demonstrating that the Elop proteins are responsible for
selection of the acyl-CoA substrates for elongation (7–13). Although
this implicates the Elop proteins as condensing enzymes, conclusive
evidence that they directly catalyze the condensation reaction is lacking.
In plants the condensation step of fatty acid elongation is catalyzed by
the FAE1-KCSs. For example FAE1, the founding member of the Ara-
bidopsis FAE1-KCS gene family, is involved in the synthesis of the
22-carbon monounsaturated fatty acid (14). Lassner et al. (15) demon-
strated that the FAE1 homolog from jojoba encodes the condensing
enzyme, 3-ketoacyl-CoA synthase (KCS), and Millar and Kunst (16)
showed that KCS regulates the substrate specificity and activity of the
elongation process. All 3-keto synthases characterized to date, includ-
ing the FAE1-KCSs, the soluble fatty acid synthases, and those involved
in polyketide synthesis, catalyze a Claissen condensation by essentially
the same mechanism (17). In these systems, studies of the mechanism,
analysis of essential catalytic residues, sequence homology, and, when
available, the three-dimensional structure reveal that all of these con-
densing enzymes have a common ancestor.
In contrast, the Elop proteins provide an exception to the notion that
all condensing enzymes involved in fatty acid elongation arose from a
common origin. The hallmarks of all condensing enzymes studied to
date aremissing from the ELO gene family. For example, all condensing
enzymes contain a conserved cysteine, which is the acyl acceptor in the
first step of themechanism. Although there are two conserved cysteines
among the Elop homologs, there is no evidence of the catalytic triad that
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is found in other 3-keto synthases. A highly conserved feature of the
Elop sequences is a histidine box, suggestive of a metal binding site, yet
no other condensing enzymes contain such a domain. The FAE-KCSs
are membrane-bound condensing enzymes with two membrane-span-
ning domains at theN terminus (18). In contrast, hydropathy analyses of
the Elop homologs predict the presence of 5–7 transmembrane
domains spread between the N and C termini.
In addition to the Elop proteins, there are several other proteins that
are required for fatty acid elongation. Each C2 elongation is a four-step
process consisting of a condensation-reduction-dehydration-reduction
cycle (see Fig. 1). The yeast YBR159w and TSC13 genes encode the
3-keto and 2,3-enoyl reductases of the elongation cycle (19–21). Con-
sistent with early biochemical characterization of fatty acid elongation
that suggested the elongase enzymes are organized in a complex (22),
the Elop, Ybr159p, and Tsc13p elongase proteins coimmunoprecipitate
with one another (20, 21). The dehydratase component of the elongase
system has yet to be identified, and whether there are other proteins
required is also not yet known.
Although yeast have no FAE-KCS homologs, several Arabidopsis
FAE-KCSs have been expressed in yeast, and these heterologously
expressed enzymes are able to direct the synthesis of novel fatty acids
(23). For example, expression of FAE1 in yeast leads to accumulation of
monounsaturated C22 erucic acid (18, 23–25). That the FAE-KCSs in
yeast lead to the synthesis of novel elongated fatty acids implies the
reconstitution of a heterologous elongase and raises several questions.
For example, can the FAE-KCSs substitute for the yeast Elop proteins?
Does the conversion of the 3-keto intermediates generated by the FAE-
KCSs into elongated fatty acids depend on the other enzymatic activities
of the elongase complex? If so, do the FAE-KCSs physically associate
with the reductases? In the studies reported here, we have addressed
these questions.
EXPERIMENTAL PROCEDURES
Media, Strains, and Genetic Manipulations—Yeast media were pre-
pared, and cells were grown according to standard procedures (26). The
yeast strains used in this study are listed in Table 1.
Disrupting the ELO1, ELO2, and ELO3 Genes—The construction of
the disruption alleleswithTRP1-replacing parts of the coding sequences
of ELO2 and ELO3 was described previously (21). The elo2::KAN dis-
rupting allele was PCR-amplified using genomic DNA prepared from
the yeast knock out collection (Invitrogen) and primers, ELO2F and
ELO2R (Table 2). To construct the elo1::KAN-disrupting allele, a PCR
fragment extending from 400 bp upstream from the start codon to 300
bp downstream of the stop codon of ELO1 was generated using the
primer pair ELO1F and ELO1R (Table 2) and genomic DNA prepared
from wild-type yeast (TDY2037, Table 1). The PCR fragment was
digested with BamH1 and SalI and ligated between the BamH1 and
XhoI sites of a Bluescript plasmid to create pBS-ELO1. The SpeI/SalI
TABLE 1
Yeast strains used in this study
Strain name Relevant genotype Complete genotype
TDY2037 Wild type Mat lys2 ura3–52 trp1 leu2
TDY7000 elo1 Mat lys2 ura3–52 trp1 leu2 elo1::KAN
TDY7001 elo2 Mata lys2 his4 ura3–52 trp1 leu2 elo2::URA3
TDY7002 elo3 Mat ura3–52 trp1 leu2 elo3::TRP1
TDY7005 elo2 elo3/pELO3 Mata lys2 ura3–52 trp1 leu2 elo2::KAN elo3::TRP1/pRS316-ELO3
TDY7006 elo1elo2elo3/pELO3 Mata lys2 ura3–52 trp1 leu2 elo1::KAN elo2::TRP1 elo3::TRP1/pRS316-ELO3
TDY7007 elo1elo2elo3/pFAE1 Mata lys2 ura3–52 trp1 leu2 elo1::KAN elo2::TRP1 elo3::TRP1/pFAE1
TDY7010 elo1elo2elo3/pAt1g04220 Mata lys2 ura3–52 trp1 leu2 elo1::KAN elo2::TRP1 elo3::TRP1/pAt1g04220
TDY7009 elo1elo2elo3/pAt5g43760 Mata lys2 ura3–52 trp1 leu2 elo1::KAN elo2::TRP1 elo3::TRP1/pAt5g43760
TDY7008 elo1elo2elo3/pAt16280 Mata lys2 ura3–52 trp1 leu2 elo1::KAN elo2::TRP1 elo3::TRP1/pAt2g16280
TABLE 2
PCR primers used in this study
Primer name Sequence
Elo2F 5-GGCCGGATCCGTACGTATTCACATGTCCTG
Elo2R 5-GGCCGGATCCTAGACATGACTGTCGAAAGG
Elo1F 5-GGCATATGGGATCCTTCTGCCAGCCAACTCAAT
Elo1R 5-GGCATATGGTCGACGTGTGACACTAGAATCGC
FAE1-PvuF 5-CCGG CAGCTGATGACGTCCGTTAACGTTAAGCTCCTTTAC
FAE1-PvuR 5-CCGG CAGCTGTTAGGACCGACCGTTTTGGACATG
FAE1-HAF 5-GGGCCCCTCGAGCACGTCCGTTAACGTTAAG
FAE1-HAR 5-GGGCCCCTCGAGTTAGGACCGACCGTTTTG
At2g16280-HAF 5-CCCGGGCTCGAGCGAAGCTGCTAATGAGCCT
At2g16280-HAR 5-CCCGGGCTCGAGTCAGAAGTCGAGCTTAAC
At5g43760-HAF 5-CCCGGGCTCGAGCAGCCATAACCAAAACCAA
At5g43760-HAR 5-CCCGGGCTCGAGCTACGACGATGTAATGGG
At1g04220-HAF 5-CCCGGGCTCGAGCAATGAGAATCACATTCAA
At1g04220-HAR 5-CCCGGGCTCGAGCTATCGAGATTCCGAGGA
At2g26250-HAF 5CCCGGGGTCGACCGGTAGATCCAACGAGCAA
At2g26250-HAR 5CCCGGGGTCGACTTAGAGAGGCACAGGGTA
At1g01120-HAF 5-CCCGGGCTCGAGCGAGAGAACAAACAGCATT
At1g01120-HAR 5-CCCGGGCTCGAGTCATTGCACAACTTTAAC
At2g26640-HAF 5-CCCGGGGTCGACCGATGTAGAGCAAAAGAAA
At2g26640-HAR 5-CCCGGGGTCGACCTAGATTGTGGAGACCTT
At1g19440-HAF 5-CCCGGGGTCGACCGACGGTGCCGGAGAATCA
At1g19440-HAR 5-CCCGGGGTCGACCTAATAACTTAAAGTTAC
At1g25450-HAF 5-CCCGGGGTCGACCTCTGATTTCTCGAGCTCC
At1g25450-HAR 5-CCCGGGGTCGACTCATAGTTTAACAACTTC
159AvrF 5-GGATCCACCATGCCTAGGACTTTTATGCAA
159AvrR 5-TTGCATAAAAGTCCTAGGCATGGTGGATCC
At159AvrF 5-GGATCCACCATGCCTAGGGAGATCTGCACT
At159AvrR 5-AGTGCAGATCTCCCTAGGCATGGTGGATCC
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fragment from pFA6a-KanMX6 (27) was substituted for the XhoI/NheI
fragment of pBS-ELO1, thereby replacing codons 10–183 of ELO1with
the kanamycin resistance marker. The pBS-ELO1::KAN plasmid was
digested with BamH1 and KpnI to liberate the elo1::KAN fragment that
was used to disrupt the ELO1 gene.
Construction and Screening of an Arabidopsis Yeast Expression
Library—Inflorescences along with small amounts of stems, leaves, and
newly initiated siliques were collected from Arabidopsis thaliana
Columbia-0 plants and used immediately for the construction of a
cDNA library in a yeast expression vector. Total RNA was initially iso-
lated from the plant material by using TRIzol reagent (Invitrogen), and
poly(A) RNA was enriched by two successive passes of the total RNA
through oligo(dT) cellulose columns (Amersham Biosciences), accord-
ing to protocols provided by the manufacturers. cDNA inserts with
EcoRI and XhoI restriction sites on the 5- and 3-ends, respectively,
were generated from 5 g of poly(A)-enriched RNA by using a Uni-
ZAP cDNA synthesis kit (Stratagene), essentially as described in the
manufacturer’s protocol, except that Superscript II reverse tran-
scriptase (Invitrogen) was used for synthesis of first strand cDNA.
Enrichment for cDNAs of between 700 and 3000 bp was conducted
with Sephacryl cDNA size fractionation columns (Invitrogen). Size-se-
lected cDNAs with flanking EcoRI and XhoI restriction sites were
ligated into the EcoRI and SalI restriction sites of a modified form of the
pADH yeast expression vector (21). Prior to its use, an EcoRI site was
introduced into the multicloning site of the pADH vector by mutation
of the HindIII site immediately adjacent to the ADH promoter. Follow-
ing incubation at 14 °C for 24 h, the ligation reaction was drop-dialyzed
against water for 15 min on 0.025-m pore size VSWP filter discs (Mil-
lipore) and transformed into Escherichia coli DH10B cells (Invitrogen)
by electroporation. Transformed cells were grown with shaking (250
rpm) for 1 h at 37 °C in 5 ml of LB media without selection. The cells
were grown for an additional 5 h with ampicillin (100 g/ml) selection
and were then inoculated into 250ml of LBmedia with ampicillin selec-
tion. Following growth at 37 °C with shaking for 8 h, plasmid was iso-
lated from harvested cells and used for yeast complementation studies.
The plasmid library was transformed into strain TDY7005 (elo2
elo3/pELO3, see Table 1), and LEU2 prototrophic transformants
were selected. The transformants (254,000) were screened for growth
on FOA, and 15 were identified that were able to lose the URA3-
marked plasmid that carried the ELO3 gene. The LEU2-marked plas-
mids from these strains were recovered, and their ability to rescue the
elo2 elo3 double mutant was confirmed. Sequence analysis revealed
that 9 carried the At5g43760 FAE-KCS cDNA, 5 carried the At2g16280
FAE-KCS cDNA, and 1 carried the At1g04220 FAE-KCS gene.
Construction of the FAE1-KCS Expression Plasmid, the HA-FAE-KCS
Expression Plasmids, and the Myc-tagged Yeast and Arabidopsis
Ybr159p—FAE1-KCSwas PCR-amplified froma cDNAkindly provided
byDr. LjerkaKunst (15) using primers FAE1-PvuF and FAE1-PvuR. The
amplified fragment was restricted with PvuII and ligated into a HindIII-
cut pADH plasmid after filling the 5-protruding ends with DNA
polymerase I. For HA tagging of the FAE-KCSs, XhoI-ended or SalI-
ended PCR products were generated that extended from codon 2
through to the stop codon for each gene. The primers used are listed in
Table 2 with the Arabidopsis At gene designator and either -HAF (for
HA-tagging primer, forward) or -HAR (for HA-tagging primer,
reverse). The PCR-generated fragments were restricted with either
XhoI or Sal1and ligated into the SalI site of plasmid pADH-3X-HA (21)
resulting in an in-frame fusion of the N-terminal triple-HA tag to each
of the FAE-KCSs. For tagging of the yeast Ybr159p and the Arabidopsis
homolog of Ybr159p (encoded by At1g67730 and hereafter referred to
as AtYbr159p), a triple-Myc epitope tag was introduced at the N termi-
nus of the pESC-Ybr159 and pESC-AtYbr159 constructs described
before (17). For this an AvrII site was first introduced after the start
codon in both constructs by QuikChange PCR mutagenesis (Strat-
agene), using the complementary mutagenic primers 159AvrF and
159AvrR or At159AvrF and At159AvrR, respectively. An SpeI-ended
fragment carrying the triple-Myc cassette was generated by PCR using a
Bluescript-based 3X-Myc-containing plasmid (19) and ligated into the
AvrII site.
Elongase Assays—Microsomes were prepared from exponentially
growing cells. Cells were pelleted at 5000  g, washed with water, and
repelleted. The cell pellets were resuspended in TEGM (0.05 M Tris
(7.5), 1 mM EGTA, 1 mM -mercaptoethanol, 1 mM phenylmethylsul-
fonyl fluoride, 1 g/ml leupeptin, 1 g/ml pepstatin A, 1 g/ml aproti-
nin) buffer at 1ml/50OD cells, and glass beads (0.5-mmdiameter) were
added to the meniscus. Cells were disrupted by four cycles of vortexing
for 1 min followed by cooling on ice for 1 min, and pelleted at 8,000 g
for 10 min. The supernatant was transferred to a fresh tube and spun at
135,000 g for 30min. The resulting pellet was resuspended byDounce
homogenization in at least a 10 volume of TEGM buffer and repel-
leted at 135,000  g. The final membrane pellet was resuspended in
TEGM buffer containing 33% glycerol and stored at80 °C.
Total elongase activitywasmeasured in a volumeof 200l containing
50mMTris, pH 7.5, 1 mMMgCl2, 150MTriton X-100, 1 mMNADPH,
1 mM NADH, 10 mM -mercaptoethanol, 1 mM dithiothreitol, 40 M
acyl-CoA acceptor, and 60 M 2[14C]malonyl-CoA (0.05 Ci/ml) at
37 °C. The reaction was initiated by the addition of 0.2 mg of microso-
mal protein. Protein concentrations were determined using the Bio-Rad
protein assay reagent (Bio-Rad). For assays of the condensing activity,
the NADPH/NADHwas omitted. The reaction was terminated after 10
min by adding 200 l of 5 M KOH/10%MeOH and heating at 80 °C for
1 h. Following addition of 200 l of 10 N H2SO4, free fatty acids were
recovered by two 1.5-ml extractions into hexane. Following evaporation
of hexane, the fatty acid methyl esters (FAMES) were generated by
dissolving in 1ml of 1 Mmethanolic HCl and heating at 80 °C for 1 h. An
equal volume of 0.15 MNaCl was added, and the FAMESwere extracted
into hexane and resolved by reverse phase C18-silica gel TLC using
CHCl3:MeOH:H2O (5:15:1) as the developing solvent. The radiolabeled
fatty acids were detected and quantified using the Cyclone Storage
Phosphor System (Packard Instrument Company, Inc., Meriden, CT).
Immunoblotting and Immunoprecipitation—Microsomes were pre-
pared from strains containing HA-tagged FAE1-KCS and the yeast
Myc-tagged Tsc13p or theArabidopsis homolog of Tsc13p (encoded by
At3g55360 and hereafter referred to as AtTsc13p) (21, 28) or the yeast
and the ArabidopsisMyc-Ybr159p (described above). The microsomes
were solubilized at 1 mg/ml with 0.1% sucrose monolaurate (Roche
Diagnostics) for 10 min, and the high speed (135,000  g, 30 min)
supernatantwas collected. The supernatant (100l) was incubatedwith
3 l of the precipitating antibody for 1 h and then with 25 l of protein
A-Sepharose (125 mg/ml from Sigma) for 1 h. The precipitates were
washed three times with 1 ml of TEGM buffer containing 0.1% sucrose
monolaurate and resuspended in 100 l of SDS loading buffer, and a
10-l sample was subjected to SDS-PAGE on a 4–12% gradient gel.
Following transfer of the separated proteins to nitrocellulose, the blots
were blocked in 0.1MTris, 7.5, 0.15MNaCl, 0.1%Tween 20, 5%drymilk.
TheMyc-Tsc13pwas detectedwith horseradish peroxidase-conjugated
monoclonal anti-Myc antibodies (Sigma) at 1/2500.HA-FAE1-KCSwas
detected using horseradish peroxidase-conjugated monoclonal
anti-HA antibodies (from Roche Molecular Biochemicals) at 1/1000.
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The bound antibodies were detected by the ECL Western blotting
detection system (Amersham Biosciences).
Fatty Acid Analysis—Cells (5 108) inmid-logarithmic growth were
harvested and resuspended in 100 l of distilled H2O along with C21
andC23 fatty acids as internal standards. Fatty acidswere extracted, and
the fatty acid methyl esters were prepared as previously described (21).
Gas chromatography/mass spectrometry (GCMS)was performed using
anHP-6890 Series GC systemwith a Supelcowax 10 column, coupled to
an HP-5973 Mass Selective Detector.
IPCAnalysis—Cells were grown in SDmedium (0.67% yeast nitrogen
base, 2% bacto-agar, 2% glucose) without inositol overnight and har-
vested during exponential growth phase. The cells were resuspended to
10 A600/ml in SD without inositol, and 50 Ci/ml myo-[2-3H]inositol
(16 Ci/mmol, Amersham Biosciences) was added. After a 10-min label-
ing, the cells were diluted to 2A600/ml with SDmedia containing 30M
unlabeled inositol and incubated for an additional 90min. Sodium azide
(4 mM final) was added, and the lipids were extracted by bead beating in
CHCl3:MeOH (1:1). The extraction was repeated, and the extracted
material was combined, clarified by centrifugation, dried, and desalted
using water saturated butanol. 250,000 cpm were spotted on TLC and
developed using CHCl3:MeOH:H2O:AcOH (16:4:1.6:4). The TLC was
dried, sprayed with EN3HANCE (PerkinElmer Life Sciences), and visu-
alized using Kodak XAR film.
RESULTS
The elo Mutants Are Affected in the Condensation Step of Fatty Acid
Elongation—A number of studies are consistent with the conclusion that
the Elop proteins participate specifically in the condensation step of fatty
acid elongation. For example, many previous studies of the Elop family of
proteins have shown that they control the substrate specificity of fatty acid
elongation (reviewed in Ref. 29). To address this question further, the con-
densation step of fatty acid elongation was assayed in vitro using micro-
somes prepared from wild-type and elo1, elo2, and elo3mutant yeast
cells. The ability of the mutant microsomes to direct the elongation of
various acyl-CoA acceptors was assessed by measuring incorporation of
label from [14C]malonyl-CoA into elongated fatty acids. By omitting
NADPH from the assay, the condensation reaction can be assayed (Fig. 1).
As shown in Fig. 2, microsomes prepared from wild-type cells form
the 3-keto condensation products by condensing malonyl-CoA with
each of the acyl-CoA substrates whenNADPH is omitted. For example,
with the C14-CoA substrate the C16–3-keto product accumulates,
with the C16-CoA substrate the C18–3-keto product accumulates, and
so forth (Fig. 2A). In contrast, when NADPH is included in the in vitro
assay, the whole series of elongated fatty acids with chain lengths up to
C26 are generated (Fig. 2A). Assays of the condensation reaction using
the microsomes from the elo mutants confirm that the Elop proteins
participate in the condensation step of elongation. Previous in vivo stud-
ies have shown that Elo1p is required for elongation of myristate to
palmitate (3, 5, 6). The in vitro assays reveal that the condensation step
is specifically affected, because microsomes prepared from cells lacking
Elo1p are unable to form the C16–3-keto product when C14-CoA is
used as a substrate for the condensation reaction (Fig. 2B). With the
elo1 mutant microsomes, the longer substrates (C16-CoA to C24-
CoA) are converted to the 3-keto products by Elo2p and/or Elo3p. The
elo2 mutant microsomes have low condensation activity toward the
C16 andC18-CoA substrates (Fig. 2C). Finally, the elo3mutantmicro-
somes form very little C24–3-keto product with theC22-CoA substrate
and no C26–3-keto product with the C24-CoA substrate (Fig. 2D).
These data provide additional evidence that the Elop proteins are
required for the condensation step of elongation.
The Arabidopsis FAE1 Gene and Other FAE-KCS Genes Rescue the
Lethality of an elo2elo3 Mutant—The yeast elo2elo3 double
mutant is inviable, reflecting that the VLCFAs have essential functions
for cell growth. Whereas the Elop proteins are needed for the conden-
sation step of fatty acid elongation in yeast, members of the FAE1-like
family of enzymes, hereafter referred to as the FAE-KCSs, catalyze the
condensation step of fatty acid elongation in plants. As discussed above,
there is no significant homology between the FAE-KCS proteins and the
Elop proteins. Although previous studies have clearly demonstrated
that FAE1-KCS expression in yeast leads to the synthesis of novel fatty
acids (16, 18, 19, 23, 25), whether the FAE-KCSs can substitute for the
yeast Elo2p/Elo3p proteins had not been tested. Therefore, it was of
interest to testwhether theArabidopsis FAE1-KCS-condensing enzyme
could rescue the lethality of the elo2elo3 double mutant.
To address this question, a yeast mutant with chromosomal disrup-
tion of both the ELO2 and ELO3 genes that carried a wild-type ELO3
gene on a URA3-marked, and therefore 5-fluoroorotic acid (FOA)-
FIGURE 1. Fatty acid elongation in S. cerevisiae. Palmitoyl-CoA is elongated to a C26-
VLCFA by the membrane-associated elongase enzymes. Each cycle of elongation
involves four successive reactions, the condensation of malonyl-CoA with the acyl-CoA
substrate, reduction of the 3-keto acyl-CoA, dehydration of the 3-hydroxy acyl-CoA, and
reduction of the trans-2,3-acyl-CoA. Although the Elop proteins have not been shown to
catalyze condensation, it is clear that theymediate substrate selection at the condensa-
tion step.
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counterselectable, plasmid was used (TDY7005, elo2::KAN
elo3::TRP1/pELO3, Table 1). The FAE1-KCS cDNA was PCR-ampli-
fied and subcloned into a LEU2-marked yeast expression plasmid
(“Experimental Procedures”). Following transformation of the FAE1-
KCS-encoding plasmid, the elo2elo3 double mutant was able to lose
the URA3-marked ELO3-rescuing plasmid (Fig. 3A). Consistent with
the in vitro assays discussed above, knowledge that the FAE1-KCS con-
densing enzyme can rescue the elo2elo3 double mutant provides
additional evidence that the Elops are required specifically for the con-
densation step of elongation.
Whether other members of the Arabidopsis FAE-KCS gene family
are able to restore viability to the elo2elo3 double mutant was inves-
tigated by screening an Arabidopsis cDNA library. A yeast expression
library was constructed by ligating Arabidopsis cDNAs behind the con-
stitutively expressed yeast pADH1promoter in a LEU2-marked plasmid
(“Experimental Procedures”). The library was transformed into the
elo2elo3 double mutant carrying the wild-type ELO3 gene on a
URA3-marked plasmid (TDY7005, Table 1), and leucine prototrophic
transformantswere selected. Those transformants that were able to lose
the ELO3-containingURA3-marked plasmid were identified by screen-
ing for growth on FOA.The cDNA-containing plasmidswere recovered
from the FOA-resistant transformants and retested to confirm that they
were able to rescue the lethality of the elo2elo3 doublemutant. Three
additional FAE-KCS genes, At2g16280, At5g43760, and At1g04220,
were identified that rescue the elo2elo3 mutant (Fig. 3A). It is likely
that other members of the Arabidopsis FAE-KCS gene family can also
substitute for the yeast Elo2p/3p proteins but that they are not as highly
represented in this cDNA expression library. It is worth noting that five
additional FAE-KCSs were PCR-amplified from the expression library,
cloned into the 3X-HA expression vector, and confirmed to be
expressed.However, theywere not able to rescue the elo2elo3 double
mutant suggesting that they are unable to elongate the endogenous
FIGURE 2. The altered VLCFA composition of the elomutants result from defects in
the condensation step of fatty acid elongation. Fatty acid elongation activity in wild-
type (A), elo1 (B), elo2 (C), and elo3 (D) mutant microsomes was compared using
C14-, C16-, C18-, C20-, C22-, and C24-CoAs as substrates. The assays were conducted in
the absence of NADPH () to measure condensation activity and in the presence of
NADPH () to measure overall elongation. The reaction products were converted to
methyl esters, extracted, and separated by reverse-phase TLC. The chain lengths of the
elongated products are indicated on the left of each panel. In the absence of NADPH, the
3-keto intermediate formed by the condensation of malonyl-CoA with the acyl-CoA
acceptor accumulates. The radiolabeled spots present in theNADPH lanes of the TLC
are actually the 2-ketones that arise from decarboxylation of the 3-keto intermediates
during thepreparationof the FAMES (38). The small amount of C16 andC18 that forms in
the absence of any added acyl-CoA (shown for the wt, labeled “None” in panel A) results
from contaminating fatty acid synthase that purifies with the microsomes, as it is elimi-
nated by including cerulenin in the assays or by deleting the FAS2 gene.
FIGURE 3. Several FAE-KCS genes rescue the lethality of the yeast elo2elo3 dou-
ble mutant. A, the elo2elo3 double mutant is unable to lose the URA3-marked plas-
mid that carries the wild-type ELO3 gene, and is therefore unable to grow on FOA. Intro-
duction of the indicated FAE-KCSgenes on a LEU2-marked yeast expression plasmid (but
not the “vector” alone) allows the mutant strain to lose the URA3-marked ELO3-contain-
ing plasmid, demonstrating that the FAE-KCS genes can substitute for the ELO3 gene.
B, the FAE-KCS genes also rescue the elo1elo2elo3 triple mutant.
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FIGURE4.TheFAE-KCSgenes restoreVLCFAsynthesis to the rescuedelo1elo2elo3 triplemutantsbutdonotcompletely reverse thephenotypesassociatedwithVLCFA
synthesis defects. A, fatty acids were extracted from wild-type, elo1, elo2, elo3, and FAE-KCS-rescued elo1elo2elo3 triple mutant cells, converted to methyl esters, and
analyzed by GCMS. C21/23 fatty acids were added to the cells as internal standards prior to extraction of the fatty acids and were used for normalization but are not shown in the
traces. The majority of the intracellular fatty acids are saturated and monounsaturated C16 and C18 (not shown in these traces) with the elongated (C18) saturated fatty acids
representing only5% of the total fatty acids (21). In wild-type yeast a high proportion (50%) of the C26 is -hydroxylated, also not shown in these traces. The insets identify the
-OH-C16, C20:0, and the C20:1 species. B, the relative abundance of the unhydroxylated saturated and monounsaturated C20–C26 and hydroxylated C16–C26 fatty acids is
presented. C, the indicated strains were grown to an A600 of 0.5 and were diluted (1/5000) into the wells of a microtiter plate. The cells were transferred to plates containing YPD
medium (1% yeast extract, 2% bacto-peptone, 2% bacto-agar, 2% glucose), and the plates were incubated at 26 °, 30 °, 33 °, or 37 °C for 3 days prior to photographing.
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substrates to provide the saturated VLCFA required for yeast viability
(see “Discussion”).
Because Elo1p is involved in synthesizing C16 and C18 fatty acids, it
was assumed that it was not required for the rescue of the elo2elo3
doublemutant by the FAE-KCSs. This was confirmed by demonstrating
that an elo1elo2elo3 triple mutant (TDY7006, Table 1) harboring
the FAE-KCS expression plasmids grew similarly to the rescued
elo2elo3 double mutant (Fig. 3B).
Characterization of in Vivo and in Vitro Activities of the FAE-KCSs—
The elongated fatty acids that accumulated in the elo2elo3 mutant
rescued by the FAE-KCSs were analyzed by GCMS (Fig. 4A). The seg-
ment of the GCMS trace from 8 to 20 min profiling the elongated
(C18) and -hydroxylated C16–C22 fatty acids is shown. Although
these are the fatty acids relevant to this study, they represent a minor
fraction (5%) of the total fatty acids, with C16, C18, and C18:1 com-
prising the majority of the yeast fatty acids. In Fig. 4B the relative abun-
dance of each of the elongated (C18) and -hydroxylated C16–C22
fatty acid species is indicated.
Consistent with previous characterizations (14, 19, 23), the predom-
inant elongated saturated fatty acid in the FAE1-KCS rescuedmutant is
C20. In contrast to wild-type yeast, there are also significant levels of
C20:1 and C22:1 in the elo2elo3mutant rescued by FAE1-KCS. This
demonstrates that, unlike Elo2p and Elo3p, FAE1-KCS is able to elon-
gate the C18:1 fatty acid that is present in yeast. The fatty acid profiles of
the At5g43760- and At1g04220-rescued elo2elo3 mutants are very
similar, with themajor VLCFA in these strains being C22. Overall, these
rescued mutants have an in vivo fatty acid composition that is very
similar to that of the elo3 mutant. The previously reported fatty acid
profiles of yeast expressing these two FAE-KCSs (23) are somewhat
different from the results reported here. In that study the genes were
expressed in wild-type yeast, and thus the fatty acid profiles reflect the
combined activities of the endogenous yeast Elo1/2/3 proteins and the
heterologously expressed FAE-KCSs (see “Discussion”). The elo2elo3
mutant rescued by At2g16280 FAE-KCS accumulates significant levels of
C24 VLCFA, making it the most similar to wild-type yeast.
Although they restored viability to the elo2elo3 mutant, none of
the heterologously expressed FAE-KCS genes restored wild-type
VLCFA profiles. As mentioned above, the fatty acid profiles of the res-
cued mutants are similar to the fatty acid profiles observed in some of
the yeast elongase mutants. For example, -hydroxylated fatty acids
with chain lengths of C16, C18, C20, and C22 accumulate, whereas in
wild-type yeast only the -hydroxylated fatty acid is the C26 species
(Fig. 4B). From our previous studies (19–21), it is clear that the shorter
-hydroxylated fatty acids arise because phytosphingosine is acylated
with shorter fatty acids in the VLCFA-deficientmutants, and the result-
ing C16–C22 ceramides are substrates for the Scs7p hydroxylase (30)
(see “Discussion”).
In addition to the altered VLCFA profiles, the FAE-KCS rescued
elo2elo3mutants display other phenotypes that are characteristic of
mutants with deficiencies in VLCFA synthesis. Similar to the elo2 and
elo3 mutants, and in contrast to wild-type cells (20, 21), the rescued
elo2elo3 doublemutants have high levels of the free long-chain bases
(data not shown). These rescued strains also display temperature sensi-
tivity, another commonphenotype of themutantswith reducedVLCFA
synthesis (Fig. 4C). The temperature-sensitive growth phenotype is
most severe for the FAE1-KCS-rescued elo2elo3 double mutant,
which is not able to grow at or above 30 °C.
The analysis of the fatty acids that accumulate in the rescuedmutants
provides information about which of the endogenous yeast fatty acids
can be elongated by the FAE-KCSs. To further investigate the activities
of the FAE-KCSs, in vitro elongase assays were conducted using micro-
somes prepared from yeast lacking the endogenous Elo1p/2p/3p pro-
teins and rescued by each of the four FAE-KCS genes. Using a variety of
different acyl-CoA acceptors, the substrate specificities of the FAE-KCS
proteins were addressed. All four of these HA-tagged FAE-KCSs were
expressed well in yeast, and similar amounts of the FAE-KCS proteins
were present in the microsomal protein preparations used for these in
vitro assays (Fig. 5A). The indicated acyl-CoAswere used at 40M in the
standard elongation assay (“Experimental Procedures”). The elongase
reactions were initiated by adding [14C]malonyl-CoA along with
NADPH, allowing overall elongation to be measured. The products
were extracted and converted to the FAMES as previously described,
and the FAMESwere resolved by reverse-phaseTLC (Fig. 5,B–E). In the
reactions without added NADPH, substrates that could be elongated
showed the expected 3-keto products (data not shown).
FAE1-KCS elongated the saturated C16- and C18-CoA substrates
well, and also elongated C20–CoA to C22, albeit less well. The
monounsaturated C16:1- and C18:1-CoA substrates were efficiently
elongated, but FAE1-KCS had little or no activity toward the C22- and
C24-CoAs or the C24:1-CoA. It also elongated the C18:2 substrate,
forming C20:2 and small amounts of C22:2. The At5g43760 FAE-KCS
displayed a strong preference for the C18- and C20-CoA substrates and
FIGURE 5. In vitro elongase activities were measured using microsomes prepared
from the FAE-KCS-rescued elo1elo2elo3 triple mutants. A, the FAE-KCS proteins
were expressed at similar levels. Microsomal protein (10 g) was prepared from the
FAE-KCS-rescued elo1elo2elo3 triplemutant and resolved by SDS-PAGE. The amino-
terminally 3-HA-tagged FAE-KCSs proteins (lane 2, HA-FAE1; lane 3, HA-At2g16280;
lane 4, HA-At5g43760; lane 5, HA-At1g04220) were detected by immunoblotting with
anti-HA antibody. The electrophoretic mobilities of the tagged FAE-KCSs were consist-
entwith their predictedmolecularmasses (60–62 kDa). Lane 1 contains protein from the
mutant expressing no HA-tagged protein, and lane 6 contains 3-HA-tagged Elo3p
(molecularmass of 43.7 kDa).B–E, fatty acid elongation activitywas assayedusingmicro-
somes prepared from each of the FAE-KCS-rescued elo1elo2elo3 triple mutants.
Microsomeswere incubatedwith the indicatedacyl-CoAs in thepresenceofNADPH, and
the reaction products were analyzed by reverse phase TLC as described in Fig. 2. The
chain lengths of the elongated products are indicated on the right side of each panel.
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had activity toward the C16-CoA and the C16:1-CoA and very low
activity with the C18:1-CoA (Fig. 5C). The At1g04220 FAE-KCS was
similar to At5g43760with activity toward the C16-, C18-, andC20-CoA
substrates, but also had low activity toward C22-CoA. It also elongated
the C16:1-, C18:1-, and C18:2-CoA substrates (Fig. 5D). The At2g16280
FAE-KCS utilized the C16–C22-CoAs and showed a strong preference
for generating the C24 product, with very little of the intermediate C20
and C22 fatty acids accumulating (Fig. 5E). Interestingly, this FAE-KCS
elongated the monounsaturated C24:1-CoA but displayed little activity
toward the C16:1, C18:1, or C18:2 substrates. The spots above fully
elongated products (especially apparent from the At2g16280-catalyzed
reactions with the C20- and C22-CoA substrates) are most likely the
3-keto (seen in the reactions run without NADPH) and possibly the
3-hydroxy elongation intermediates.
The FAE-KCSs Coimmunoprecipitate with Ybr159p and Tsc13p, the
Reductases of the Elongase Complex—The ability of the FAE-KCS
enzymes to direct VLCFA synthesis in yeast raised questions as to
whether this elongation pathway is dependent upon the other charac-
terized components of the yeast Elop-containing elongase system. We
have shown that Ybr159p is themajor 3-keto reductase (19, 20) and that
Tsc13p is the trans-2,3-enoyl reductase required for fatty acid elonga-
tion (21, 28). Furthermore, immunoprecipitation experiments have
shown that these reductases, alongwith the Elop proteins, are organized
in a complex. Because the FAE-KCSs are not homologous to the Elops,
it was an open question as to whether they could associate with the
other elongase proteins. However, the activity of FAE1 in yeast is
dependent on Ybr159p (19), arguing that this component of the elon-
gase is responsible for reducing the 3-keto intermediate generated by
the FAE-KCSs. In addition, expression of the FAE-KCS genes did not
bypass the slow growth phenotype of the ybr159mutant or the lethal-
ity of the tsc13mutant (data not shown).
Whether the FAE-KCSs physically associate with the reductases was
tested directly by immunoprecipitation experiments. Membranes were
prepared from cells coexpressing HA-tagged FAE1 with either Myc-
tagged yeast or Myc-tagged Arabidopsis Tsc13p (Fig. 6A). Membranes
were also prepared from cells co-expressing HA-tagged FAE1 with
either Myc-tagged yeast or Myc-tagged Arabidopsis Ybr159p (Fig. 6B).
Following solubilization, the microsomal proteins were immunopre-
cipitated with either HA or Myc antibodies. Samples of the solubilized
membranes (Tot), along with the supernatants (Sup) and pellets (Pell)
from the immunoprecipitations were immunoblotted with anti-HA or
anti-Myc antibodies. TheHA antibodies immunoprecipitated theMyc-
tagged yeast Tsc13p and Myc-tagged Arabidopsis Tsc13p proteins
along with the HA-tagged FAE1. Conversely, theMyc antibodies pulled
downHA-tagged FAE1 along with theMyc-tagged yeast andArabidop-
sis Tsc13p. The HA-tagged FAE1 also coimmunoprecipitated with
Myc-tagged Ybr159p fromArabidopsis and to a lesser extent withMyc-
tagged yeast Ybr159p (Fig. 6B). Theweak interaction between FAE1 and
yeast Ybr159p compared with its interaction with the Arabidopsis
Ybr159p homolog is discussed further below (“Discussion”). Coimmu-
noprecipitation experiments using theHA-taggedAt2g16280 FAE-KCS
and Myc-tagged yeast and Arabidopsis Tsc13p confirmed that this FAE-
KCS also associates with Tsc13p (Fig. 6C). These results demonstrate that
the FAE-KCSs physically associate with the Tsc13p trans-2,3-enoyl reduc-
tase and the Ybr159p 3-keto reductase of the elongase system.
To determine whether FAE-KCSs and Elops can interact with the
same elongase complexes, we also tested whether Elo3p coimmunopre-
cipitated with HA-FAE1 (Fig. 6D). The HA-FAE1 was expressed in
wild-type yeast cells, and solubilized microsomal protein was immuno-
precipitated with anti-HA-conjugated Sephadex beads. The failure to
see any Elo3p (whichmigrates as three discrete bands due to differential
glycosylation) coimmunoprecipitated with the HA-tagged FAE1 sug-
gests that elongase complexes can form with either an Elop protein or a
FAE-KCS protein, but not with both. The failure of Elo3p to coimmu-
noprecipitate with HA-FAE1 also demonstrates the specificity of the
interactions of the FAE-KCSs with the reductases. It is important to
note that the level of endogenously expressed Elo3p is higher than the
levels of the HA-FAE-KCSs. This is evident from Fig. 5A, which shows
that HA-Elo3p (expressed from its own promoter and thus reflecting
endogenous Elo3p levels) is more abundant than the HA-tagged FAE-
KCSs. The specificity of the association of the FAE-KCSs with the
reductases is also underscored by the finding that an HA-tagged Arabi-
dopsis Elop-like protein (At3g06460) failed to coimmunoprecipitate
with Myc-tagged Arabidopsis or yeast Tsc13p (Fig. 6E). Finally, HA-
tagged FAE1 also failed to coimmunoprecipitate with the endoplasmic
reticulum-localized Lcb1p protein providing additional evidence for the
specificity of the coimmunoprecipitations (data not shown). Taken
together, these results strongly suggest that the FAE-KCSs associate
specifically with the reductases of the elongase complex.
The VLCFA Synthesized by the Heterologously Expressed FAE-KCSs
Are Incorporated into Inositolphosphoceramides—The experiments
above demonstrate that the FAE-KCSs interact with the yeast elongase
complex and direct the synthesis of sufficient VLCFA to rescue the
lethality of an elo2elo3 double mutant. In yeast, the majority of the
VLCFAs are found in the sphingolipids, primarily the inositolphospho-
ceramides (IPCs). The IPCs are synthesized from the ceramides, which
are in turn generated by joining the VLCFA in amide linkage with
phytosphingosine in a reaction catalyzed by ceramide synthase (Fig.
7A). Because sphingolipids are essential for yeast cell viability, it appears
that ceramide synthase is capable of using the VLCFA derived from the
FAE-KCSs to acylate phytosphingosine, creating ceramides that can be
converted to IPCs. The appearance of the-OHC16–C22 fatty acids in
the rescued mutants provides indirect evidence that the VLCFA pro-
duced by the FAE-KCSs are incorporated into ceramides, because Scs7p
hydroxylates the fatty acid in ceramides. To directly test whether the
FAE-KCS-derived VLCFAs are incorporated into sphingolipids, the
FAE-KCS rescued elo1elo2elo3 triple mutant cells were labeled
with inositol, and the extracted IPCs were analyzed by thin layer chro-
matography. As shown in Fig. 7B, each of the FAE-KCS-rescued
elo1elo2elo3 triple mutants synthesized IPCs. Whereas the IPC in
wild-type yeast contains exclusively-OHC26 fatty acid (labeled as “26”
Fig. 7B), mutants lacking Elo3p accumulate C22 IPC-C. The reduced
hydrophobicity of theC22 IPC-C relative to theC26 PC-C is reflected in
its lower mobility in the thin layer chromatographic analysis. Interest-
ingly, the C22 IPC-C that accumulates in the elo3mutant is not man-
nosylated; like the csgmutants that fail to convert IPC toMIPC (31, 32),
the elo3 mutant makes IPC but no MIPC or M(IP)2C (Fig. 7B). With
the exception of the strain expressing At2g16280, the IPCs that are
synthesized by the FAE-KCS-rescued elo1elo2elo3 triple mutants
are relatively hydrophilic and, like the C22 IPC-C that accumulates in
the elo3 mutant, they are not mannosylated. The data are consistent
with the fatty acid analyses (Figs. 4). For example, in the FAE1-rescued
mutant, C20 is the major VLCFA in the cells and C20-IPC-C accumu-
lates. Similarly, in the At5g43760- and At1g04420-rescued mutants,
C22 is the predominant fatty acid and C22 IPC-C accumulates. The
At2g16280-rescued mutant accumulates C24 and thus C24-IPC-C;
unlike the IPCswith shorter fatty acids, this IPC species ismannosylated
(note the appearance of MIPC). The spots above the indicated IPC-C
species (and below PI) are IPC-B species that lack the -hydroxylation
on the fatty acids (30). The appearance of these IPC-B species in the
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mutants that accumulate the C20 and C-22 IPCs suggests that the fatty
acid chain length of the IPCs affects their hydroxylation by Scs7p.
DISCUSSION
The large number of different FAE-KCS isozymes (22 inArabidopsis)
is believed to reflect their activities toward different acyl-CoA substrates
as well as the fact that some of the genes display tissue-specific expres-
sion. There are no FAE-KCS homologs in the yeast genome. Rather, the
Elop family of proteins is believed to catalyze the condensation step of
fatty acid elongation in yeast, as well as in other eukaryotes, including
mammals. The evidence that the Elop proteins are responsible for con-
densation relies in part upon the finding that heterologously expressed
FIGURE 6. FAE1 coimmunoprecipitates with the
reductase components of the elongase com-
plex. A, HA-tagged FAE1 was co-expressed with
Myc-tagged yeast Tsc13p (top) or Myc-tagged
AtTsc13p encoded by the At3g55360 gene (bot-
tom). Microsomes were prepared, solubilized, and
immunoprecipitated with anti-HA antibodies,
anti-Myc antibodies, or unconjugated Sephadex
beads. The total soluble protein (Tot), supernatant
(Sup), and pellet (Pell) from each immunoprecipi-
tation was detected by immunoblotting with
anti-HA (left) or anti-Myc (right). B, as in A, except
that the HA-tagged FAE1 was coexpressed with
Myc-tagged yeast Ybr159p (top) or Myc-tagged
AtYbr159p encoded by the At1g67730 gene (bot-
tom). The proteins migrate as predicted by their
molecular masses, 41.4 kDa for yeast Myc-Tsc13p,
40.4 kDa forMyc-AtTsc13p, 38.7 kDa for yeastMyc-
Ybr159p, 40.4 kDa for Myc-AtYbr159p, and 60 kDa
for HA-FAE1. C, HA-tagged At2g16280 (62.2 kDa)
was coexpressed with Myc-tagged yeast Tsc13p
(top) or with Myc-tagged Arabidopsis Tsc13p (bot-
tom). Microsomal protein (Tot) was solubilized
(Sol) and immunoprecipitated with anti-HA or
anti-Myc antibodies or with unconjugated Seph-
adex beads. The immunoprecipitates were immu-
noblotted with anti-HA antibodies. D, HA-tagged
FAE1 was expressed in a wild-type yeast and
immunoprecipitated with anti-HA antibodies or
unconjugated Sephadex beads. Total microsomal
protein (Tot) solubilized protein (Sol) and the pel-
lets from the immunoprecipitations (unconju-
gatedbeads or anti-HA antibodies)were immuno-
blotted with anti-HA (left) or with anti-Elo3p
(right). Elo3p, with a predicted molecular mass of
39.5 kDa, runs as a broad band due to glycosyla-
tion. E, the HA-tagged Arabidopsis Elop-like pro-
tein (At3g06460, 38.2 kDa) was coexpressed with
Myc-tagged yeast Tsc13p (top) or with Myc-
tagged Arabidopsis Tsc13p (bottom), and the solu-
bilized proteins were immunoprecipitated with
anti-HA or anti-Myc antibodies. The immunopre-
cipitates were immunoblotted with anti-HA (left)
of anti-Myc (right) antibodies.
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Elop homologs can direct the synthesis of novel fatty acids in yeast.
Because the Elop proteins have none of the hallmarks of the well char-
acterized 3-ketoacyl-CoA synthases, they either represent a completely
novel type of condensing enzyme or they could be a regulatory subunit
that confers acyl-CoA substrate recognition to an as yet unidentified
condensing enzyme. In this regard, it should be noted that the dehy-
dratase activity of the elongase system has not been identified, so it is
entirely possible that additional elongase proteins will be identified.
We have recently reported that Ybr159p is the major 3-ketoreduc-
tase, and that Tsc13p is the trans-2,3-enoyl reductase of the yeast elon-
gase system (19–21). Furthermore, we found that these enzymes coim-
munoprecipitate with one another and with the Elop proteins, a result
FIGURE 7. The FAE-KCS-derivedVLCFAs are incorporated into inositolphosphoceramides. A, the pathway for synthesis of the IPC,MIPC, andMIP2C sphingolipids in S. cerevisiae.
B, wild-type, elo3, and the FAE-KCS- rescued elo1elo2 elo3 triplemutant cells were incubatedwith [3H]inositol and the inositol-containing lipids were visualized by autoradiog-
raphy following separation by TLC. Whereas the ceramide backbone of the IPC-C species in wild-type cells is comprised exclusively of PHS and an -OH-C26 fatty acid, in the
FAE-KCS-rescuedmutants, IPCs with shorter chain lengths (C20–C24) are seen. The ceramides of the relatively hydrophobic IPC-Bs contain an unhydroxylated fatty acid. In addition
to the inositolphosphoceramides, phosphatidylinositol (PI) as well as lyso-PI are present.
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that is consistent with early biochemical characterizations that sug-
gested that the elongase enzymes are organized in a complex (33).
Despite the lack of sequence homology between the Elop and FAE-KCS
proteins, the data presented here demonstrate that the FAE-KCSs act in
conjunctionwith the reductases of the elongase complex. The coimmu-
noprecipitation data strongly suggests that the FAE-KCSs physically
associate in a complex with the Ybr159p and Tsc13p reductases. This
raises the intriguing possibility that the Elop and FAE-KCS proteins
evolved independently as distinct 3-keto-CoA synthases and yet are able
to interact with the other components of the elongase complex.
Although the significance is unclear, we previously observed that all of
the known components of the yeast elongase complex (Elo1p/2p/3p,
Ybr159p, and Tsc13p) have a high pI ( 10), and we note that the
FAE-KCSs also have high pIs (9.2). The coimmunoprecipitation
results indicate that FAE1 interacts more strongly with the Arabidopsis
Ybr159p homolog than with yeast Ybr159p. Although it is tempting to
speculate that this reflects differences between the Ybr159p proteins
that affect their associationwith FAE1, there is currently no information
as to which proteins of the elongase complex are in direct contact.
In addition to the large FAE-KCS gene family, there are also several
Elop homologs inArabidopsis, the roles of which have not been defined.
On the other hand, there is a single homolog of Tsc13p, the trans-2,3-
enoyl reductase inArabidopsis (encoded byAt3g55360 that functionally
complements a yeast tsc13 mutant (28). Kunst and coworkers (34)
recently reported the characterization of anArabidopsismutant lacking
the Tsc13p homolog, referred to in that study as ECR. The mutant
displayed reduced synthesis of VLCFA, and decreased cuticular wax,
storage lipid, and VLCFA-containing sphingolipids. Although the
plants displayed morphological abnormalities that could be specifically
attributed to the sphingolipid deficiency, the plants were viable and
accumulated some VLCFA, indicating that there is at least one other
reductase that can reduce the trans-2,3-CoA intermediates in Arabi-
dopsis (34). It is unclear whether the residual fatty acid elongation that is
occurring in the mutant plants is dependent on the FAE-KCSs, or
whether it might be mediated by the Arabidopsis Elop homologs.
There are two genes that encode 3-ketoacyl-CoA reductases with
homology to Ybr159p in both Arabidopsis (At1g67730 and At1g24470)
and maize (gl8a and gl8b). The gl8a and gl8b genes of maize are 97%
identical to one another, and both are required for normal accumulation
of cuticular waxes. Double mutant kernels accumulate substantially
reduced levels of VLCFAs and ceramides and are inviable suggesting
that sphingolipids or otherVLCFA-containing compounds are essential
for normal embryo development (35). It is important to point out that
the Arabidopsis reductase genes are able to substitute for their yeast
counterparts (20, 21). Because yeast have no FAE-KCSs, these plant
reductases clearly interface with the Elop proteins to restore fatty acid
elongation in the yeast mutants. The role of the Arabidopsis ELOS has
yet to be established, but it is likely that they function analogously to
their yeast homologs and that the plant 3-keto and trans-2,3-enoyl
reductases act with both FAES and ELOS in plants.
In this study four Arabidopsis FAE-KCSs that are able to substitute
for the yeast Elo2p/Elo3p proteins by directing the synthesis of satu-
rated VLCFA is reported. It is likely that additional members of the
Arabidopsis FAE-KCSs will also functionally complement the
elo2elo3 double mutant, but that they were not recovered, because
they are either not present or are poorly represented in the Arabidopsis
yeast expression library. For example, despite the fact that FAE1 does
complement and that we were able to PCR amplify it from the expres-
sion library, it was not found in the complementation screening. The
characterization of the complementing FAE-KCSs confirms that yeast
require saturated VLCFAwith aminimal chain length of C20 for viabil-
ity. As mentioned under “Results,” five additional FAE-KCSs
(At2g26250, At1g01120, At2g26640, At1g19440, and At1g25450) were
PCR-amplified from the library and expressed in yeast, but were unable
to rescue the elo2elo3 double mutant. Thus, they apparently cannot
elongate the available substrates (mainly C16 in the elo2elo3mutant)
to produce the required VLCFA. It will be interesting to characterize
their substrate specificities using the in vitro elongase assays.
The heterologous expression of several FAE-KCS genes in wild-type
yeast was recently reported (23), including several that were also char-
acterized in this study. Three of the six that were found to be enzymat-
ically active in that study (FAE1, At5g43760, and At1g04220) were
among those that were found to be capable of complementing the
elo2elo3 double mutant. Expression of At1g01120 was reported to
result in the accumulation of C22, -24, and -26 VLCFA and expression
of At1g25450 in the accumulation of C26, -28, and -30 (23), but we
found that neither was able to rescue the elo2elo3 double mutant.
Thismay reflect the difference in expressing the genes inwild-type yeast
instead of in the elo2elo3 double mutant. For example, if these FAE-
KCSs elongate fatty acids with chain lengths greater than C18, these
substrates would have been available (produced by Elo2p/Elo3p) in a
wild-type background but not in the elo2elo3 double mutant back-
ground. Previous studies of yeast expressing theAt1g01120 (KCS1) gene
suggested that it does elongate C18, -20, -22, and -24 fatty acids (36). It
is possible that the coexpression of some of these noncomplementing
FAE-KCSs together with FAE1 in the elo2elo3 mutant will result in
the ability to grow at 37 °C, a nonpermissive temperature for the FAE1-
rescued mutant (Fig. 4B). For example, an FAE-KCS that elongates C20
substrates, alongwith FAE1 that elongates the C16 produced by de novo
fatty acid synthesis toC20,would restore synthesis ofVLCFAC22 and
thereby would likely restore growth at 37 °C.
Although this study confirms that the VLCFA produced by the FAE-
KCSs fulfills the essential function missing in the elo2elo3 mutant,
the rescued strains are not completely normal. For example, the FAE1-
KCS-rescued mutant is unable to grow at temperatures above 30 °C, a
phenotype shared by a large number of mutants with reduced sphingo-
lipid synthesis (37). This may reflect a role of the VLCFA-containing
sphingolipids in reducing membrane fluidity at elevated temperatures.
Furthermore, although only C26 ceramides are produced in wild-type
yeast, the mutants accumulate ceramides with shorter chain lengths.
Interestingly, the shorter ceramides are inositolphosphorylated by
Aur1p, but the IPCs with fatty acids shorter than C24 are not substrates
for mannosylation as no MIPC or M(IP)2C is generated.
In summary, we present here the finding that FAE-KCS proteins can
substitute for the yeast Elop proteins. Surprisingly, although yeast have
no FAE-KCS homologs, the FAE-KCS proteins apparently associate
with the other components of the yeast elongase complex.
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